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Abstract 
Intensive care clinicians are presented with large quantities of patient information and 
measurements from a multitude of monitoring systems. The limited ability of humans to 
process such complex information hinders physicians to readily recognize and act on early 
signs of patient deterioration. We used machine learning to develop an early warning 
system for circulatory failure based on a high-resolution ICU database with 240 patient-
years of data. This automatic system predicts 90.0% of circulatory failure events (prevalence 
3.1%), with 81.8% identified more than two hours in advance, resulting in an area under the 
receiver operating characteristic curve of 94.0% and area under the precision recall curve of 
63.0%. The model was externally validated in a large independent patient cohort. 
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Critical illness is characterized by the presence or risk of developing life-threatening organ 
dysfunction. Critically ill patients are typically cared for in intensive care units (ICU), which 
are designed to provide the highest level of patient observation and support. ICUs specialize 
in providing continuous monitoring and advanced therapeutic and diagnostic technologies 
such that organ function can be maintained while the underlying illness or injury is treated. 
An integral aspect of patient care is regular patient evaluation, including assessing changes 
in organ function parameters over time and in the context of established treatments. Many 
ICUs now use electronic patient data management systems (PDMS) to centrally store and 
manage patient-specific data, and enable easily-interpretable display of trend data on 
bedside monitors. Collected data includes measurements of organ function parameters with 
high temporal resolution, results of diagnostic tests, and parameters determined by 
therapeutic interventions.  
ICU physicians are presented with large and growing quantities of data from many patients 
and it is increasingly difficult to identify the most important information for care decisions. 
The limited ability of humans to process such quantities of information can lead to data 
overload, change blindness, and task fixation1. Critical care settings are therefore vulnerable 
to problems related to failures by clinicians to readily recognize, interpret, and act upon 
relevant information2,3, leading to delays in care provision. Crucially, in a majority of 
patients the causes of deterioration are potentially treatable and most interventions will be 
more efficient if initiated early4–6. A common approach to identify patients at risk of organ 
system deterioration is the use of medical device alarms for individual physiological 
measurements based on critical thresholds. Since such alarm systems lack access to 
comprehensive information their alarms are often nonspecific7,8 and lead to alarm fatigue, 
which was rated seventh on the list of top 10 technology hazards from the ECRI Institute9,10. 
Machine learning techniques excel in the analysis of complex signals in data-rich 
environments11,12. Recent advances in deep learning, reinforcement learning, and other 
machine learning techniques have enabled and popularized their use in mathematics13, 
engineering14, biology15 and medicine16–26,77. The abundance of data collected in the ICU and 
the importance of timely decision-making are key to the growing interest of using of 
machine learning in this setting.  
The potential of data analysis using modern machine learning methods is not well 
established in a ICU context29. With some exceptions28,30,31, only simple statistical models for 
 
 
4 
detection or prediction of specific conditions have been developed and deployed32–38. 
Despite being based on relatively few features and including far fewer information 
categories than those available to clinicians, these models showed acceptable prediction 
results for the examined prediction problems. In the machine learning community, likely 
spurred by the availability of datasets such as MIMIC-III39, intensive care has attracted 
significant research interest. Endpoints such as patient mortality40 and length of stay (LOS)41 
are commonly tackled using predictive models. However, after the initial decision to admit a 
patient to ICU for full treatment the accurate prediction of mortality or LOS is not of great 
importance for further treatment decisions. Patient state deterioration besides mortality 
has also been addressed in the context of ICU admission42 or the onset of treatment43. 
Prediction of circulatory failure has not been extensively explored, with existing work 
focusing primarily on specific aspects such as hypotension44 and vasopressor use45, or 
related problems like sepsis prediction28,46,47 and renal failure30.  
In this work, we develop a novel approach based on medical knowledge, large-scale data 
analysis, and state-of-the-art machine learning techniques to construct two early warning 
systems for circulatory failure in ICU patients. These systems, named circEWS (/ˈsərkəs/) and 
circEWS-lite, are of differing complexity and alert clinicians to patients at risk of circulatory 
failure in the next 8 hours. We define patients as being in circulatory failure if they a) have 
elevated lactate (≥ 2 mmol/L), and b) have either low blood pressure (MAP≤ 65 mmHg) or 
are receiving vasopressors or inotropes. To train the early warning system, we use a large 
database from a multidisciplinary ICU in a tertiary care center in Berne, Switzerland, 
containing physiological variables, diagnostic test results, and treatment parameters 
routinely collected from more than 54,000 ICU admissions. With close to 5,000 variables 
collected and continuously monitored parameters updated every 2 minutes, this dataset 
contains over 3 billion data points. It has higher temporal resolution compared to the two 
publicly available ICU datasets (MIMIC-III39 contains around 312 million data points and 
eICU48 contains around 827 million) and non-ICU datasets19,20,22, allowing better 
characterization of patient states49. We have developed a comprehensive analysis 
framework including data pre-processing and cleaning, feature extraction and 
interpretation, and a selection of large-scale supervised machine learning techniques to 
construct circEWS.  
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To evaluate the performance of circEWS, we established an alarm/event-based evaluation 
measure, which assesses the fraction of circulatory failure events correctly predicted (i.e., 
an alarm was raised for this event) and the false alarm rate (i.e., there was an alarm but no 
event). For external validation we applied different versions of our system to the MIMIC-III 
database.  
 
Results 
Preparation of a high time resolution ICU data set (HiRID) 
The full dataset contained a total of 4,959 different routinely collected physiological 
variables, diagnostic test results, and treatment parameters from 54,225 patient admissions 
to the ICU (Supplementary Fig. 1 shows an example). After applying exclusion criteria 
(Supplementary Fig. 2a,b), information from 710 variables concerning 36,098 patient 
admissions during the period from January 2008 to June 2016 remained for further 
processing (Supplementary Tab. 1 shows a summary of patient characteristics). After 
merging redundant variables and inclusion of static patient characteristics, 209 consistently 
measured variables were used for model development (Fig. 1a, Supplementary Fig. 2c). This 
was achieved by aggregating pharmaceutical variables across administration routes and 
dosages, and summarizing measurement modalities of physiological variables 
(Supplementary Fig. 4a). The data was resampled to 5-minute resolution using adaptive 
imputation for missing measurements (Fig. 1b). The patient’s circulatory state was 
annotated for each time point as “circulatory failure”, “no circulatory failure”, or 
“ambiguous” (insufficient data for annotation) (Fig. 1c). Overall, we identified 45,886 
instances of circulatory failure in 11,046 patients with a mean event duration of 320 
minutes. We found that ICU mortality correlated with longer duration and higher number of 
events of circulatory failure (Supplementary Fig. 3). We aim to release the pre-processed 
data to the research community on Physionet78 in order to enhance reproducibility and 
enable academic re-use of this dataset. 
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Fig. 1: Model development overview.  
Data preparation: a: Data on patient admissions were exported from the ICU patient database management system (PDMS) and filtered 
according to inclusion/exclusion criteria. Relevant variables for the prediction problem were identified. Clinically implausible values, 
variable-specific errors, and other artefacts were automatically excluded using variable-specific algorithms. Pharmaceutical variables 
determined by differing administration methods were merged to produce effective administration rates over time. Different monitoring 
modalities for the same parameter were merged. b: Adaptive imputation was performed by resampling the data to a 5-minute time grid 
and filling missing values using a patient and variable-specific imputation scheme. c: The circulatory state was annotated according to the 
circulatory failure definition. Machine learning: d: At each time-point, four feature types (intensity, multi-resolution summaries, instability 
history, shapelets) per variable were extracted and together with static patient information represented the data available at this time 
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point. e: To construct the binary prediction problem, each relevant time-point was labelled as either “positive” (circulatory failure occurs 
in the next 8 hours) or “negative” (circulatory failure does not occur in the next 8 hours). f: A binary classifier to predict near-term 
circulatory failure was trained on the extracted labels and features. A gradient-boosted ensemble of decision trees was chosen as the 
classifier after benchmarking different methods. Evaluation: g: The proposed early warning system for circulatory deterioration, called 
circEWS, consists of the trained binary classifier, a decision threshold, and a policy of silencing for a short period after alarms. The system 
was evaluated based on the fraction of alarms which are correct (precision), and the fraction of circulatory failure events which are 
correctly predicted (recall). 
 
Development of a machine-learning framework for prediction of circulatory failure 
Using the HiRID data, we constructed a two-class dataset for machine learning based on the 
patient’s near-future circulatory state. All time points annotated as “no circulatory failure” 
(i.e., not currently in a circulatory event state) were labelled as “positive” if circulatory 
failure occurs in the next 8 hours, otherwise “negative” (Fig. 1e). Ambiguously labelled time 
points were excluded from training and evaluation. We extracted a high-dimensional 
feature vector per time point, which included static patient information, multi-scale 
summaries of time series history, measurement intensity of variables, and temporal 
patterns (Fig. 1d). Overall, the dataset contained 15 million labelled time slices of which 
3.1% were labelled positive. With all available imputed features/labels the dataset was ≈300 
GB in size. We developed an analysis framework that is capable of dealing with such large 
datasets and supports feature selection, model selection, and evaluation of temporal 
datasets. Based on an advanced experimental setup and evaluation strategy 
(Supplementary Fig. 4b), we tested and compared multiple state-of-the-art machine 
learning approaches, including deep learning. Among different classifiers, gradient-boosted 
ensembles of decision trees (lightGBM50) were found to offer the best overall performance 
(Supplementary Fig. 5d,e). 
Two classifiers with differing complexity were developed - “full” and “compact” models. 
From the 710 variables in the dataset, 5,278 features were constructed and ranked 
according to mean absolute SHAP value51 which indicates their importance for predictions 
on the validation set. The "full" model uses the top 500 features, originating from 112 
variables (Supplementary Tab. 5). We then determined commonly available variables that 
were ranked within the top 20 according to mean absolute SHAP value (Table 1; specifically, 
we require the variable to be available in MIMIC-III). This lead to a list of 17 variables that 
produce 176 features which are used in the “compact” model. As a baseline, a decision tree 
model was developed, which uses only the last measurement of each of the three variables 
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included in the definition of circulatory failure (MAP, lactate level, and dosage of 
vasopressors/inotropes). This baseline model mimics a traditional threshold-based rule 
system based on a small number of variables. The areas under the receiver operator curves 
(AUROCs) with respect to the time point-based labeling of the full, compact, and baseline 
models were 94.0%, 93.9%, and 88.3%, respectively (Fig. 2a). The areas under the precision 
recall curves (AUPRCs) are more informative for rare events and were 46.7%, 45.4%, and 
25.4% for full, compact, and baseline models, respectively (Supplementary Fig. 5a). 
 
 
Table 1: Table of the top 20 ranked variables for the prediction of circulatory failure. The ranking was obtained by first ranking all 5,278 
features according to their importance in explaining predictions of the development model and then greedily selecting clinical variables in 
a forward-selection procedure if they contribute to important features derived from these variables. The point estimate of the rank is 
obtained on the held-out data split, and the standard deviation of the rank was obtained on five splits of the data. The last column lists the 
important feature categories for a variable, i.e., the feature categories that contribute to the top 50 features overall. The categories are 
sorted by decreasing importance in terms of rank in the list of top features. MAP: Mean arterial pressure, BP: Blood pressure, RASS: 
Richmond Agitation Sedation Scale, INR: International Normalized Ratio (Prothrombin time). Variables not contained in MIMIC III are 
marked by * and were not used in the compact model (and hence also not the circEWS-lite system) as they appear to be less commonly 
available.  
Rank (std) Variable Important feature categories
1 (0.0) Lactate Current, Shapelet, Multi-resolution,
Instability history, Measurement
2 (0) MAP Multi-resolution, Instability history, Current,
Shapelet, Measurement
3 (5.3) Time since ICU admission N/A
4 (0.4) Patient age Static
5 (3.0) Heart rate Current, Multi-resolution, Measurement,
Shapelet
6-9 (2.3) Dobutamine, Instability history, Multi-resolution
Milrinone,
Levosimendan*,
Theophylline*
10 (5.3) Cardiac output Shapelet, Multi-resolution, Measurement
11 (3.5) RASS Current, Multi-resolution, Measurement
12 (34.6) INR Measurement, Multi-resolution, Current
13 (5.8) Serum glucose Multi-resolution, Current, Measurement
14 (4.4) C-reactive protein Multi-resolution, Current, Measurement
15 (7.9) Diastolic BP Multi-resolution, Shapelet, Measurement
16 (4.0) Peak inspiratory pressure (Ventilator) Current, Measurement, Multi-resolution,
Shapelet
17 (7.9) Systolic BP Current, Multi-resolution, Measurement, Shapelet
18 (10.6) SpO2 Multi-resolution, Shapelet, Measurement
19 (17.8) Non-opioid analgesics* Multi-resolution
20 (11.4) Supplemental oxygen Multi-resolution, Measurement, Current
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The circulatory early warning system (circEWS) 
Our model generates a prediction score every 5 minutes that is associated with the risk of 
the patient experiencing circulatory failure in the next 8 hours. A simple, threshold-based 
warning system derived from this prediction score could lead to a continuous stream of 
alarms every 5 minutes, causing alarm fatigue. We therefore developed a more advanced 
alarm system that triggers an alarm when the likelihood for circulatory failure exceeds a 
specified threshold. It also implements a silencing policy: once an alarm is triggered, 
subsequent alarms are then suppressed for 30 minutes (Fig. 1g). If the patient experiences 
circulatory failure and recovers during the silencing period, the system is “reset” and 
unsilenced to potentially inform clinicians about recurrence of circulatory failure. The effects 
of different silencing periods and reset times are shown in Supplementary Fig. 6. We applied 
this alarm algorithm to the predictions of our full and compact model, and called the 
resulting systems circEWS and circEWS-lite, respectively. The performance of the two 
systems is shown in Fig. 2b, using precision-recall curves52 (PRC) to illustrate different trade-
offs of precision and recall. Recall was defined as the fraction of events with any alarm in 
the preceding eight hours (excluding the five minutes immediately prior to the event) and 
precision as the fraction of alarms which correctly predicted an event. Precision and recall 
measure performance on the raised alarms and occurring events, respectively, and are 
clinically more meaningful than time point-based measures. It should be noted, that for rare 
events (only 3.1% of time points are labelled positive), predictions with high precision are 
much more difficult to obtain than small false positive rates. Recall as a function of time 
before occurrence of circulatory failure for fixed overall recall and precision is shown in Fig. 
2e. We observe an increase in the rate of correctly predicted events closer to the onset of 
circulatory failure, with 81.8% of the events identified more than 2 hours in advance. The 
timeliness of circEWS alarms is further illustrated in Fig. 2f, showing the temporal 
distribution of the first alarm and number of alarms in the 8-hour window prior to 
deterioration. The results imply that, if a medical practitioner with an 8-hour shift was to 
react to every alarm from circEWS, every patient would be checked only every second shift 
and on average 2 hours 32 minutes before circulatory failure (Fig. 2f). 
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Fig. 2: Model performance. a: Receiver-operating characteristic (ROC) curve for the binary classification task of predicting circulatory 
failure, comparing our two proposed models to a baseline model. The full model contained 500 features (composed from 112 variables) 
and the compact model contained 176 features (composed from 17 variables). The baseline model only used variables included in the 
definition of circulatory failure and is based on a decision tree. b: Precision-recall curve for the circEWS/circEWS-lite alarm systems built on 
top of the full/compact classification model from panel a, using 30min silencing. Recall was defined as the fraction of events for which the 
system correctly raised an alarm from 8 hours to 5 min before the event. Precision was defined as the fraction of alarms which are in a 
window of 8 hours prior to a circulatory failure event. c&d: External validation: The compact model (circEWS-lite) was tested on the 
MIMIC-III ICU dataset and evaluated using ROC and PR curves, in analogy to panels a and b. MIMIC (Validation) denotes the performance 
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of the model trained on the HiRID dataset, and applied on the MIMIC-III data set, MIMIC (Retrain) denotes a model re-trained and tested 
on MIMIC-III data splits. Reported precision in MIMIC was corrected to reflect the different prevalence in MIMIC compared to HiRID e: 
Using a sliding 30-minute window, the fraction of events that are correctly retrieved by alarms as early as a certain time in (t,8] h before 
circulatory failure is reported. f: Shown is the distribution of the first alarm in the 8 hours before an alarm (top). The time to deterioration 
from the first alarm was on average 2 hours and 32 minutes. The bottom shows the distribution of raised alarms in 8 hour windows not 
immediatly followed by an event. We found the distribution is not uniform and hypothesize that this is due to past and future 
deterioration events (i.e., outside of the 8h period). In all panels, metrics are reported ± denoting standard deviation.  
 
External validation 
The publicly available ICU dataset MIMIC-III39 was used for external validation. The 17 
variables required for circEWS-lite were identified in MIMIC (Table 1, Supplementary Table 
5). We performed identical pre-processing of the MIMIC-III data with minor modifications to 
account for a lower time-resolution in MIMIC-III and different encodings. We report the 
performance of circEWS-lite on this MIMIC test set as MIMIC (Validation) in Fig. 2c,d. 
Additionally, model training was repeated on MIMIC; results are reported as MIMIC 
(Retrain). In both cases, we corrected the label prevalence to be equal to the observed 
prevalence in HiRID, enabling comparison of precision in Fig. 2d (before correction MIMIC 
has 1.8% in contrast to HiRID’s 3.1% positive labels). AUPRC results for uncorrected 
prevalence are shown in Supplementary Fig. 7c.  
Inspection of model features 
We used SHAP values51 to assess the importance of individual features of circEWS. For a 
given prediction, the influence of each feature on the classifier output is expressed as a 
SHAP value, with positive and negative SHAP values indicating an increase or decrease 
respectively, on the prediction score.  
In Fig. 3a, we list the top 15 features by mean absolute SHAP value, and show the 
distribution of SHAP values across all predictions. Unsurprisingly, features from variables 
used to define circulatory failure rank highest. The relationship between feature value and 
SHAP value is illustrated in more detail for the features Patient age and MAP in Fig. 3b,c, 
with further examples in Supplementary Fig. 8. Table 1 reports the 20 most relevant 
variables (also used to define circEWS-lite). We analyzed the effect on the AUPRC of 
removing each of these variables in turn, and found that only the removal of lactate 
noticeably decreased performance (resulting AUPRC 41.1 ± 3.7%). Greedy forward selection 
of variables guided by performance on the validation set confirms lactate and MAP as the 
most important variables, as in the analysis based on SHAP values. Model performance 
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begins saturating after adding around 10 variables (Supplementary Tab. 4). Fig. 3d shows 
the highest-ranking lactate shapelet as an example from the shapelet feature class, 
illustrating that the SHAP value of the feature increases 5.5 hours before onset of 
deterioration. 
 
 
Fig. 3: Feature inspection. a: Top 15 features according to their mean absolute SHAP values. On the y-axis, the black violin plot shows the 
full distribution of the SHAP values for this feature. The dot plot in the foreground shows a colour-coding of the actual value of the feature 
resulting in the SHAP value on the x-axis. The color-coding is based on the percentile of the feature value in respect to the whole 
distribution. b&c: Scatter plots showing the relationship between feature value and SHAP value for age and lowest MAP in the last hour. 
The orange line represents the mean; standard deviation is given in shaded orange. The distributions of the SHAP values and feature 
values are shown as histograms on the right side and the top of the main graph. The high variance in the SHAP value for a given feature 
value indicates a strong influence of other features. d: Shapelet feature illustration: The lactate shapelet has an increase in its SHAP value 
(gray) 5.5 hours before the patient suffers from deterioration (first arrow). Shown in light blue is the feature value that represents the 
distance between time series and shapelet at 4 hours in the past. The feature value drops right before the event, increasing the prediction 
score (second arrow). 
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Model performance in different patient cohorts 
In all subsequent analyses with fixed thresholds, we chose a threshold leading to a recall of 
90.0%, resulting in a precision of 29.6% for circEWS. Results for the system with recalls of 
80.0% and 95.0% are shown in Supplementary Fig. 10. 
To study if the model performs similarly across different types of patients, we evaluated 
circEWS in different cohorts: varying age, severity of illness at the time of ICU admission, 
APACHE diagnostic groups, and compared medical and surgical patients as well as elective 
and emergency admissions (Fig. 4a-c, Supplementary Fig. 9c,e). We find similar performance 
across most diagnostic groups, with the exception of neurological patients for whom the 
model performs worse, with an event recall of 76.6% compared to 91.2% across all patients 
in the rest of the cohort (corrected p-value 0.038, dependent 2-sample t-test). For 
neurosurgical patients, the model exhibits a decreased precision of 8.1% compared with 
30.0% in the rest of the patients (p-value 0.0006, dependent 2-sample t-test). Patients with 
lower APACHE scores (0-15) have lower precision of 19.7% compared with 30.5% in the rest 
of the cohort (p-value 0.0004, dependent 2-sample t-test, Fig. 4b). Emergency admissions 
have lower recall of 88.2% compared with 93.6% for elective admissions (p-value 0.039), 
whereas surgical admissions have a higher recall of 92.3% compared with 87.7% in the rest 
of patients (p-value 0.039, Supplementary Fig. 9e). 
Model performance over time  
Fig. 5a shows how the performance of the model varies as time since admission increases. 
While the overall recall of the model is 90% (Supplementary Fig. 10 for other thresholds), 
the performance is not uniformly distributed across a typical patient’s stay, with recalls of 
over 95% attained within the first 8 hours. After the first day, the overall recall of the model 
drops to around 83%. Supplementary Fig. 11a,b shows how event duration and time since 
the previous event affect recall. Using our dataset spanning 8 years, we also analyzed how 
changes in medical practice and patient characteristics may impact model performance in 
the future. We simulated the setting of using a trained model over a number of years into 
the future in a reverse way as follows: we fixed a test set comprised of patients admitted in 
2016, and constructed eight training sets; one for patients admitted in each of the years 
2008-2015. This design was chosen to eliminate the performance variability caused if one 
would use different test sets. In Fig. 5b, we report the performance of these eight models in 
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terms of AUPRC and precision at fixed recalls (AUROC shown in Supplementary Fig. 11c). To 
control for the effect of training set size on performance, each training set was subsampled 
to have comparable size (2,366 patients). We observed a slight increase in performance the 
closer the test set is to the training set (Supplementary Fig. 11c). We observe different 
degrees performance variation the closer the test set is to the training set (Fig. 5b). By fitting 
an autoregressive model to the differences of the AUPRC values, we observe a first order 
term of size 0.14 which we interpret as the presence of a temporal drift35. This does not 
hold for the precision values (Fig. 5b), where we can assume stationarity (p-value 5*10-5, 
Dickley-Fuller test35). 
 
Fig. 4: Performance in different patient cohorts. Shown analyses use circEWS with a threshold corresponding to 90% recall, silencing of 
30min, corresponding to an overall precision of 30%. a: Recall and precision for patients in different APACHE diagnostic groups. The 
notation (n: a/c, s:b/d) below each group name means that there are a and b patients with events among c and d patients in its non-
surgical and surgical subgroup respectively.  b: Recall and precision for patients stratified by APACHE-III score. The notation (a/d) under 
each group name means that there are a patients with events and d patients in the group. c: Recall and precision as a function of patient 
age.  
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Fig. 5 Performance over time. a: Recall as a function of time since admission. Events (episodes of circulatory failure) are stratified based 
on time lag after ICU admission. In the top graph, we show the cumulative performance of the model, i.e., after 8 hours the overall recall 
of the model is approximately 96%. The lower graph reports the recall for each time period independently. b: Temporal generalization: we 
assessed how a model trained on historical data generalizes to a test set increasingly distant in the future. To do this, we fixed a test set 
using data from 2016 and train 8 models, each using one year of data between 2008-2016. We report here the AUPRC as a function of the 
year the model was trained, and the precision at a fixed threshold (baseline prevalence shown in red). 
 
Discussion 
We have demonstrated that two variants of a machine learning-based early warning system 
(circEWS and circEWS-lite) can predict circulatory failure with very high recall – only a small 
fraction of events are missed and most events are detected several hours before an event. 
Since the prevalence of events is low, it is not easy to achieve a low false-alarm rate. Our 
system generates about one false warning per day and patient, which we consider very low 
compared to other warning systems in clinical practice and definitely low enough to be of 
clinical utility. circEWS, based on 500 features from 112 clinical variables performed best, 
but was only marginally better than circEWS-lite, based on 176 features from 17 of the most 
important variables. Performance was similar irrespective of diagnosis, severity of illness, 
and age – with a few notable exceptions (neurologic patients). Unsurprisingly, recall of the 
model was highest immediately prior to circulatory failure. Nevertheless, most events could 
be detected several hours in advance to allow for appropriate interventions to be initiated. 
The alarm system was tested on an independent patient group from a different hospital 
system and demonstrated very good performance, despite the lower temporal resolution of 
the available data. 
The main limitations of our study are related to the single-center design, which creates a 
risk of over-fitting the model to the patient cohort and data at hand. However, the analyzed 
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ICU admissions originate from a population covering the whole spectrum of ICU patients 
and external validation demonstrates the applicability of our model in other ICUs. Further, it 
was not possible to retrospectively identify patients in whom supra-normal blood pressure 
values were targeted. High blood pressure targets are often set to maintain cerebral 
perfusion pressure in critically ill neurological or neurosurgical patients. These patients can 
have elevated lactate levels due to localized intracerebral ischemia or due to inadequate 
blood supply, or from surgical retraction54–56, and therefore would fulfil our endpoint 
definition without being in circulatory shock. Their inclusion is likely to impair model 
performance, and we observed inferior performance of circEWS in this patient group.  
circEWS was constructed with data collected in a clinical context, containing artefacts and 
errors. No manual data cleaning was performed. This ensures that similar performance can 
be expected once the model is applied on live data. The low prevalence of the endpoint was 
not artificially increased to improve apparent model performance, but left unchanged to 
mirror future applications of the model as realistically as possible.  
Conventional systems that help identify patients at risk of circulatory deterioration in the 
ICU are based on variables known to determine circulatory function and tight alarm limits 
are set. Often lacking clinical relevance, such alarms can lead to alarm fatigue when medical 
staff is overwhelmed by excessive alerts57. In comparison to traditional alarm systems, 
circEWS integrates individual patient information and a large variety of physiological 
measurements from multiple organ systems to achieve a manageable number of timely 
alarms and thus reduces the chance of alarm fatigue57. While the reported precision of 30% 
at a recall of 90% appears low at first sight, the system raises an alarm only every 16h per 
patient and 82% of events are identified more than two hours in advance. This would give 
physicians enough time to evaluate the situation and take appropriate measures if needed. 
In our evaluation we are not able to detect cases where the physician intervened by 
treatment which lead to an improved state of the patient and to an avoidance of the 
deterioration event. These would be counted as false positives and decrease the estimated 
precision of circEWS.    Therefore, we expect that the precision in practice is higher than we 
estimate. 
The ability to interrogate model predictions and to understand which features contributed 
to a given prediction is important for ensuring that this technology remains interpretable to 
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its clinical users. Using SHAP values, we see that the model identified established predictors 
determined by circulatory state, but also time series representations, information from 
other organ systems, patient characteristics, and treatment parameters. Although in-depth 
analysis of feature importance is beyond the scope of this study, such an analysis in the 
future might offer new insights on previously unrecognized indicators of circulatory failure. 
Removing individual variables to inspect model performance indicated that of the top 20 
variables identified by SHAP values, only the exclusion of lactate resulted in markedly 
decreased performance. This finding indicates that there is redundancy across variables and 
features; this effect is also seen when we ablate entire feature categories (Supplementary 
Fig. 12). The high relevance of the lactate variable suggest that more frequent 
measurements of lactate will likely lead to a performance increase and to an earlier 
detection of deterioration events. 
To assess the external validity of circEWS, we applied it to the MIMIC-III ICU dataset. We 
observed that if we apply circEWS-lite directly to MIMIC, its performance remains high, 
degrading only slightly. Interestingly, when we retrain the classifier on MIMIC, the 
performance of the system only improves slightly, and for thresholds resulting in high recall, 
actually performs worse. This may be related to the quantity of data available in MIMIC-III 
to train models - the usable training data is much smaller (2.8 million vs. 13 million samples 
in HiRID) and the fact that the temporal resolution is much lower (in MIMIC, variables such 
as MAP are provided on average hourly - in contrast to a sampling frequency of 2 minutes in 
HiRID). As observed in Supplementary Fig. 5b, even with the large training size available in 
HiRID, the model’s performance has not yet saturated with respect to training set size, and 
therefore, the more limited data in MIMIC may impair performance. 
The practice of medicine changes as new research is conducted and new technologies are 
developed. Machine learning methods trained on historical data are therefore susceptible 
to reduced performance associated with future deployment58. Our results indicate a slight 
increase in model performance the closer the derivation is to the test set, providing 
evidence for this effect. Moreover, medical practice varies between providers as well as 
institutions. The importance of this locational dataset shift is illustrated in our results by the 
observation of better performance of the locally re-calibrated MIMIC retrain model versus 
the MIMIC validation. Our model should therefore not be seen as an unalterable and 
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universal scoring system similar to traditional ICU scores. In a clinical setting, it will be 
important to continually monitor the quality of predictions using new data to constantly 
develop and re-calibrate the models to account for temporal changes and local differences 
in practice. The high time resolution and size of the HiRID data set make it valuable for 
further applications of machine learning. We are therefore in the process of making the data 
publicly available for research. 
Machine learning techniques have been applied to tasks in radiology59, pathology60, and 
critical care28,30 in retrospective clinical studies. Approaches spanning a spectrum of 
complexity have been developed to tackle clinical prediction problems, from linear 
models61–63 to complex deep architectures64. In this work, we used gradient-boosted 
decision trees due to their observed superior performance in our application and ease of 
interrogation. This model class has been successfully applied in many different domains65–67. 
While we tested other models, including recurrent neural networks, we found these 
approaches inferior (see Supplementary Fig. 5e). This finding reflects recent observations19 
that careful feature design, combined with state-of-the art machine learning approaches, 
can outperform deep learning; in particular, when limited amounts of data are available. 
However, when more data is available for training the system it is likely that more 
expressive deep architectures may ultimately prove superior. Finding an existing system 
with which to compare circEWS is challenging. Methods have been developed to predict 
single aspects of circulatory failure including the time of initiation of vasopressors66 or the 
onset of acute hypotensive episodes67. In the case of the former, an AUROC of 92% was 
achieved for vasopressor need within 2 hours, although other, clinically more relevant 
metrics are not reported. In the latter study, the algorithm predicted arterial hypotension 15 
minutes before the hypotensive event with a sensitivity and specificity of 88% (AUROC 95%; 
precision was not provided). The prediction of septic shock has also been addressed, for 
instance, the TREWScore22 identifies patients before the onset of septic shock with an 
AUROC of 83% (with 85% sensitivity at specificity of 67%). Ultimately none of these methods 
directly addresses our prediction problem, hence we have constructed an internal baseline 
method. 
Our data shows that even short periods of circulatory failure are associated with an increase 
in ICU mortality. While this does not prove causality, it is safe to assume that preventing 
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prolonged times of circulatory failure will likely decrease ICU mortality. Considering the 
demonstrated good performance of our models, we hypothesize that machine learning-
based early warning systems may help ICU staff to more rapidly identify patients at risk for 
development of circulatory failure with a much lower false positive alarm rate than 
conventional threshold-based systems. Models developed on a local retrospective dataset 
can be transferred to other ICUs and be applied in the future. Nevertheless, performance 
will likely increase when models are retrained to the specific settings. Before clinical 
application of our models is possible, prospective research on the impact of model 
implementation on patient outcomes has to be conducted. Overall, we show that adaptive 
models have the potential to allow the shift from detection and treatment to automated 
prediction and hopefully prevention of organ system failure.  
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Online methods 
Study design and setting  
The study was designed as a retrospective cohort study for the development and validation 
of a clinical prediction model. The study was performed at the Department of Intensive Care 
Medicine of the Bern University Hospital, Switzerland (ICU), an interdisciplinary 60-bed unit 
admitting >6,500 patients per year. Data processing, model training, and analyses were 
performed at the Departments of Computer Science as well as Biosystems Science and 
Engineering at ETH Zürich, Switzerland. 
Ethical approval and patient consent  
The institutional review board (IRB) of the Canton of Bern approved the study. The need for 
obtaining informed patient consent was waived due to the retrospective and observational 
nature of the study.  
Participants and data sources  
The study included all patients admitted to the ICU in the period between the 
implementation of the ICU electronic patient data management system (PDMS; GE 
Centricity Critical Care, General Electrics, Helsinki, Finland) in April 2005 and August 2016. 
The PDMS was used to prospectively register patient health information, measurements of 
organ function parameters, results of laboratory analyses and treatment parameters from 
ICU admission to discharge. 
The study flow chart is presented in Supplementary Fig. 2a. Patient admissions prior to 2008 
were excluded from the analysis due to frequent changes in variable identifiers during the 
run-in phase of the PDMS implementation. Patients without data for determining circulatory 
failure and patients receiving any form of full mechanical circulatory support, younger than 
16 years or older than 100 years, or actively declining the use of their data for research 
purposes were excluded. 
Analysis platform 
All computational analyses were performed on a secure compute cluster environment 
located at ETH Zürich (https://scicomp.ethz.ch/wiki/Leonhard). Python3, with numpy68, 
pandas69 and scikit-learn70 formed the backbone of the data processing pipeline.  
  
 
 
21 
Artefact removal 
Artefact removal and correction was performed using variable-specific algorithms to enable 
future live deployment and constituted a major effort. Four main types of artefacts were 
identified: 
• Timestamp artefacts: Measurement time information was stored in two fields - the 
time the measurement was taken (SampleTime), and the time it entered the system 
(EnterTime). While the latter field was automatically filled, SampleTime can contain 
manual input errors, such as an incorrect month or even year, disrupting the order of 
the time series, or falsely indicating unreasonably long ICU stays or gaps between 
measurements. Intervals longer than 1 day were identified and corrected as 
described in Supplementary Tab. 3. Timestamp artefacts existed in 3,530 (8%) of 
patient admissions. 
• Variable-specific artefacts: Blood gas samples required a manual selection of the 
sample type as arterial or venous. As arterial is the default option, multiple venous 
samples were wrongly labeled as arterial. This was identified by comparing the 
oxygen saturation in the blood gas sample to the central venous saturation - if this 
difference was less than 10% of the standard deviation of oxygen saturation (across 
the training data), the sample was re-labelled as venous. Patient height and weight 
were manually entered and sometimes accidentally interchanged. For weight/height 
measurements resulting in Body Mass Indices (BMI) > 60kg/m2 or < 10kg/m2, height 
and weight were swapped if this resulted in a BMI in the range of 10-60 kg/m2. 
• Out of range artefacts: For each variable, a range of possible values (including 
pathologic values) was defined - these are reported in Supplementary Tab. 5 (column 
“permitted range” in variables tab). Values outside this range were deleted.  
• Record duplication: The database contained records of the same variable for the 
same patient with the same timestamp. For non-pharmaceutical variables one value 
was kept if the values of the duplicates were identical. Otherwise, we compared the 
standard deviation of the duplicates with the global standard deviation of the 
variable across all patients. If the former was <5% of the latter, we kept the mean of 
the duplicates. Otherwise, the duplicates were considered unreliable and deleted. 
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• For pharmaceutical variables duplicates with an entry indicating a “zero” dose were 
deleted. For duplicates of drugs applied as tablets or injections the sum of the 
recorded dose values was kept. For duplications with a status indicating none of the 
above, we took the mean of the dose. 
• Processing pharmaceutical variables: We converted all pharmaceutical variables to 
either a rate or presence indicator. Drugs given as boluses such as injections and 
tablets were converted to an effective continuous rate over a time-period specified 
according to the estimated duration of action (Supplementary Tab. 5, column “acting 
period (individual)” in drugs tab). In cases where a quantitative rate is not possible, 
we used a binary flag to indicate if the drug (or drug class; see next section) was 
present. 
Variable merging  
The PDMS contained many instances of the same parameter being recorded using different 
identifiers (e.g., different dilutions of vasopressors, different probe locations for core 
temperature measurements). Moreover, specific variables were infrequently observed (e.g., 
foscavir was observed < 50 times), but belonged to a meta-category (such as “Antiviral 
therapy”). To build a model which is less specific to the local patient cohort/setting, we used 
the following variable merging strategies, reducing our set of variables from 710 to 209. 
Identical medical core concepts recorded as different variable ids were merged (e.g., 
different probe locations for core temperature measurements). Identical pharmaceutical 
compounds were aggregated into one variable (Supplementary Fig. 4a). 
Certain clinically less important compounds were aggregated to group variables regarding 
the targeted pharmaceutical effect (e.g., non-opioid analgesics, Supplementary Tab. 5, 
columns “drug” and “constituent drugs (if relevant)” in drugs tab). This was performed for 
better temporal and inter ICU generalizability by making the model features independent of 
the specific compound used. If this led to multiple measurements at the same time, the 
following strategies were used. For physiological parameters (such as temperature) or lab 
tests, we used the median of simultaneous measurements. For pharmaceutical variables, we 
used a weighted sum over simultaneous infusions, with weighting given by effective relative 
doses determined by analysis of the literature. Otherwise, we merged variables into a binary 
indicator denoting whether or not any drug from that class (e.g., antibiotics) was present, or 
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count how many drugs are present (Supplementary Tab. 5, column “merging ratio” in drugs 
tab). 
Circulatory state annotation 
We annotated every 5-minute interval of a patient’s stay with their current circulatory state 
using three types of variables: lactate (arterial and venous), mean arterial blood pressure 
(MAP), and presence of vasoactive/inotropic drugs. The state was established using a 
window of 45 minutes duration centered on the current time-point. To reduce spurious calls 
due to transient states, in each such window all conditions had to be independently true for 
30 minutes (not necessarily consecutive).  
We defined the following three states: 
• Patient currently not in circulatory failure: if MAP is >65 mmHg, vasoactive/inotropic 
drugs are not present, and lactate is ≤2 mmol/L. 
• Patient currently in circulatory failure: MAP is ≤65 mmHg or (not exclusive) 
vasoactive/inotropic drugs are present and lactate is >2 mmol/L 
• Unknown/Ambiguous: if any of the following conditions hold: 
- No MAP or (interpolated) lactate is available in the 45-minute window 
- MAP or vasoactive/inotropic drug criterion is met, but lactate is ≤2 mmol/L 
To enable state annotation at all time-points, we imputed lactate values between 
measurements. We linearly interpolated lactate values between measurements, unless the 
patient’s lactate value had passed the threshold of 2 mmol/L in either direction. If a 
patient’s state had changed, from either low to high lactate or vice-versa, we linearly 
interpolated depending the interval between the two measurements. If they were less than 
six hours apart we interpolate for the full period. Otherwise we forward/backward filled for 
a maximum of 3 hours and the remaining time points were left missing. 
To handle the starts/ends of the stay, we filled forward/backward. If the patient’s first/last 
measurement was “normal” (under the threshold), we backward/forward filled indefinitely. 
If the measurement was abnormal, we filled backward/forward for up to 3 hours. 
As this imputation scheme implicitly used information from the future, it was only used for 
annotating (and subsequently labeling) timepoints. Adaptive imputation and feature 
generation for model development were performed independently and as described below 
without using future information. 
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Patient-centered adaptive time series imputation 
Imputation parameters were pre-computed on the training set. They consist of the 
median/IQR of the sampling interval of each non-medication variable 𝘪, denoted as (𝑚𝘪, 𝘪𝘲𝘳𝘪) 
below. The imputation process created a time grid with step size 5 minutes, starting and 
ending at the patients first and last heart rate measurements, or ending at 28 days after 
admission (whichever is shorter). This provided a unified definition of “beginning of stay”, 
corresponding to the start of basic monitoring, and avoids biasing the data towards patients 
with very long stays. Values were imputed for all variables independently at each grid-point 
using the following process. Prior to the first measurement of a given variable, or if the 
patient had no measurements, we filled it in using a normal value (Supplementary Tab. 5, 
column “default value” in variables tab). If the last measurement, as seen from the grid 
point, was less than 𝑚𝘪 +𝘪𝘲𝘳𝘪 minutes away, we used forward filling from the last value. 
Otherwise we linearly returned to the median of the last 2*(𝑚𝘪 + 2*𝘪𝘲𝘳𝘪) minutes, as 
measured from the point where we entered the region where this imputation mode is 
applied, for 2*(𝑚𝘪 + 2*𝘪𝘲𝘳𝘪) minutes in total. After that, we assumed that the value stayed 
constant at this median value (indefinite forward-filling), until the next valid measurement, 
if any, at which we returned to step 2. Static variables were imputed according to either the 
mean or the mode value in the training data, for continuous and categorical values 
respectively. 
Feature generation 
Feature generation took as input the imputed data and generated features sample-wise on 
the 5-minute grid. The first 30 minutes of a stay were ignored for feature generation, 
because the history of vital signs and lab tests contained insufficient information to 
generate reliable features. Six types of features were generated for each time grid point. 
They included the current estimated value of a variable, and five others, which are 
described in detail below. Besides these feature classes, we also added “time since 
admission” as an individual feature. 
• Static features: Six static features (Age, Indicator of Surgical Admission, Indicator of 
Emergency Admission, APACHE Patient Group, Height and Sex) were concatenated 
to each time-grid sample of a patient. 
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• Multi-resolution summaries: To capture the temporal history of our data, we 
constructed time windows of increasing size and extract summary statistics over 
each window (Fig. 1d). The window sizes and statistics depended on the variable 
type and sampling rate. We classified each variable as either of high, low, or medium 
frequency according to its median sampling interval in the training set, or estimated 
duration of action for medications (Supplementary Tab. 5, in drugs tab). For each 
frequency category, we defined four time windows for short, medium, long, and very 
long time horizons using prior clinical knowledge (Supplementary Fig. 13a). For 
continuous-valued variables, we extracted the median, IQR, minimum/maximum 
values, and a trend estimate for each of the time horizons. We reported a mean 
estimate rather than median for medications. For categorical and binary variables, 
we reported only the mode or mean respectively. Additionally, we summarized the 
entire stay up to now with the summary functions mode, mean, or median 
depending on the variable category.  
• Instability history features: Assuming that patients who have already suffered 
circulatory instability are at increased risk of recurrence, we formed a set of features 
to capture the patient’s history of instability. We encoded the current state, time to 
the last pathologic state as well as the density of pathological states in the past. All 
of these refer to logical sub-conditions of our circulatory failure definitions 
(Supplementary Tab. 13b). If no abnormal state was measured, we set a symbolic 
value of 30 days (larger than the maximum length of a stay). The density was defined 
as the ratio of the duration the state was active and the length of the stay so far. 
• Measurement-intensity based features: Since imputation removed information about 
when and how often measurements were performed, we reintroduced some of this 
information with this feature class for vital sign measurements and lab tests. We 
report the time since the last (non-imputed) measurement (30 days, if no 
measurement available) as well as the ratio of time points with measurements in the 
stay up to now. 
• Shapelet-based features: A shapelet is a small time series subsequence that is 
discriminative for the class label and known to capture salient temporal dynamics of 
time series in a variety of application domains71,72. We used the computationally 
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efficient S3M method73: For each variable, 300 subsequences were extracted with a 
padding of 5 min before any deterioration event; these were labelled as cases 
(Supplementary Fig. 13c). The same number of uniformly sampled time series from 
the remaining patients served as controls. The remaining parameters were adjusted 
according to the resolution of the variable (see Supplementary Fig. 13c). As the 
resulting shapelet set might be very large (up to multiple 1,000 shapelets per 
variable), the subsequent shapelet selection step created a feasible number of 
shapelet features per variable (in our case 20 shapelets per variable and length) that 
was representative of the space of all shapelets with the min-max approach: First, 
the shapelet with the highest accuracy in differentiating cases from controls on the 
training data set was selected. Afterwards, shapelets were iteratively selected such 
that the minimal distance to the set of already selected shapelets was maximized 
until 20 shapelets are chosen (Supplementary Fig. 13d). Supplementary Fig. 12d 
shows that the min-max sampling gave similar performance as random sampling or 
selecting the top 20 shapelets. A shapelet was used to construct a set of features per 
time point by concatenating the L2 distances between the shapelet and the history 
of a patient's variable during the last 4 hours. This history of distances (dist-hist) 
approach outperformed other feature computation approaches as shown in 
Supplementary Fig. 12d: Single distance (distance), the minimum over all distances in 
the last 4h (min) and counting the number of shapelets that have occurred in the last 
4h (count). 
Supervised learning of deterioration prediction 
We defined a binary prediction task to be performed every 5 minutes while a patient is not 
in circulatory failure (otherwise, a warning would be too late). At each such time point, the 
model predicted whether the patient will develop circulatory failure in the next 8 hours 
(positive label), or not (negative label). If the patient’s circulatory state during the next 8 
hours cannot be determined, no label was assigned and the time-point was excluded from 
training and evaluation. To avoid overestimating the prospective performance of our model 
(see Supplementary Fig. 5c for an illustration of this effect), we used an experimental design 
in which the test set contains the most recently admitted patients in the cohort (see 
Supplementary Fig. 4b); we call this a “temporal split”. In a given temporal split, the full 
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methodology was applied independently, including missing data imputation, feature 
extraction, model training and hyperparameter selection. 
Five overlapping temporal splits were constructed, each containing admissions across 5 
years (Supplementary Fig. 4b). The admissions of the last year were split 1:1 to define the 
validation and test sets, respectively. The remaining earlier admissions were used as training 
set of that split. The start of each subsequent split was shifted by six months. Further, the 
most recent 10% of patient admissions (November 2015 to May 2016) were defined as the 
held-out evaluation set which was not used for model development to avoid subtle 
overfitting to this data-set. This set was also split 1:1 into held-out validation and test sets. 
Using the rest of the available data as training data, this held-out set formed a special “held-
out” split, which was used to provide a point estimate of model performance. The five 
temporal splits were used to estimate the variability of model performance, containing 
disjoint test sets, and partially disjoint training sets. We report this variability as the 
standard deviation over model performance in these splits. Lastly, an exploration split was 
defined which assigns patients at random to training, validation and test set in proportions 
8:1:1. This split was used to compare temporal generalization to the standard approach of 
randomly assigning admissions to training and test set (Supplementary Fig. 5c). 
Machine learning approaches 
We compared the following three state-of-the-art supervised machine learning techniques to 
learn to detect deterioration events: 
• Gradient boosted ensemble of decision trees, and decision tree baseline: The gradient 
boosting library lightGBM (version 2.2.1) was used for model fitting33. The 
hyperparameter settings maximizing the AUPRC on the validation set were used to 
generate the predictions on the test set, after refitting on the training set. The model 
training process was stopped if the AUPRC on the validation set did not improve over 
50 consecutive fitting iterations, resetting the model state to the best iteration 
before early stopping. Since lightGBM can deal natively with categorical data, we did 
not one-hot-code such data before model fitting. As this model achieved highest 
performance during system development, it was used for further analyses. To obtain 
the decision tree baseline, we set the number of trees to 1.  
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• Logistic regression: The class SGDClassifier from the scikit-learn library (version 
0.20.0) was used for model fitting70. The strength of the regularization parameter 
was selected by maximizing the AUPRC on the validation set. Before fitting, 
continuous features were standardized (zero mean, standard deviation one), and 
categorical features one-hot-encoded. 
• LSTM-based recurrent neural network model: We constructed a long short-term 
memory (LSTM)74 network comparison in TensorFlow 1.11.075. We used the same set 
of features as provided to lightGBM for fair comparison after intermediate results 
suggested worse performance when using only the raw variable values. Since a 
fraction of the features are static, a small-size single-layer-perceptron (SLP) was used 
alongside the LSTM to learn from the static features. The LSTM and the SLP output 
the hidden states for the dynamic and the static features respectively, and by linear 
combination these two hidden states are fed into the output layer. Before training, 
all non-categorical features were standardized and categorical features one-hot-
encoded. 
Hyperparameter settings and grids for the following models are listed in Supplementary 
Tab. 2, if not otherwise described. 
Variable and feature selection 
The importance of individual features was measured using mean absolute SHAP values of 
predictions made on the validation set for each temporal split. Before SHAP values were 
computed, the negative instances in the validation set were sub-sampled to achieve a 
balanced dataset. The variable ranking was obtained with a greedy forward selection 
approach where the variable associated with the feature with the largest mean absolute 
SHAP value considered the most important variable. This variable and all its features were 
then removed from the ranking and the procedure was repeated. The final ranking of 
important clinical variables was determined using the held-out split. The standard deviation 
of the ranks is computed on the five temporal splits used for model development. Optimal 
model performance was obtained using 500 features, and removing more features 
degraded performance (Supplementary Fig. 12e). These features, comprising 112 variables, 
are provided to the full model. We further identified the top 20 clinical variables using the 
ranking procedure (see Table 1) and excluded three variables not identifiable in MIMIC 
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(“non-opioid analgesics” and two inotropes). The resulting 176 features from the remaining 
17 variables formed the compact model. 
Early warning system and evaluation 
A core contribution of this work is an early warning system for circulatory failure within 8 
hours - circEWS. We built two variants, circEWS and circEWS-lite, based on the binary 
classifiers “full” and “compact” described above. The output of the classifier is a score 
between 0 and 1, which is converted to an alarm if it exceeds a fixed threshold. On top of 
this, we employed a silencing policy to reduce unnecessary repetitive alarms: For 30 
minutes after an alarm is raised, any potential subsequent alarms were suppressed. If a 
patient experienced circulatory failure and recovered during this silencing period, the 
system was reset to allow new alarms after 25 minutes. Effects of different silencing periods 
and system reset times are shown in Supplementary Fig. 6. Our objective was to evaluate 
circEWS in a clinically relevant context, focusing on the percentage of circulatory failure 
events the system is able to detect and the rate of false alarms. Model precision was 
defined as the fraction of alarms that correctly predict the onset of an event (a period of 
circulatory failure) within the next 8 hours. Model recall was defined as the fraction of 
events that are captured by an alarm. This is analogous to exon prediction in gene finding76. 
Significance of performance differences in patient sub-cohorts was assessed using a p<0.05 
cutoff using dependent 2-sample t-tests corrected for multiple-testing with the Benjamini-
Hochberg procedure, matched on the 6 temporal splits in which the experiment was 
replicated. 
External validation on MIMIC-III 
MIMIC-III v1.4 was used for external validation, including only patients admitted after 2008 
and the introduction of MetaVision. 17 of the 20 most important variables (Table 1) were 
identified and extracted. Non-opioid analgesics could not be matched. The drugs 
levosimendan and theophylline were not used at Beth Israel Deaconess Center and were 
excluded. Since many of the artefact removal steps described above are specific to HiRID, 
we applied only artefact removal using the same fixed variable specific ranges on the MIMIC 
data. MIMIC data was converted into the correct format to be processed by the rest of the 
HiRID pipeline. Patient state annotation, label generation, and missing data imputation were 
performed as described above with minor modifications.  
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Imputation parameters: Part of our imputation pipeline required calculating the sampling 
interval for each variable. These intervals were not recomputed to provide similar data for 
validation to our existing model. Furthermore, we did not expect the ground truth of these 
values to vary much between ICUs, even if different down-sampling is used.  
Time grid: The temporal resolution of MIMIC was different to that of HiRID. Nonetheless, to 
mirror the HiRID data structure as closely as possible, we resample MIMIC to a five-minute 
grid, even if this introduces a large quantity of imputed data. 
We consider two settings for evaluating circEWS-lite on MIMIC: “MIMIC (Validation)”, and 
“MIMIC (Retrain)”. In the validation setting, we applied circEWS-lite on MIMIC, using the full 
dataset as a test-set (in total 9,040 patients; see Supplementary Fig. 2b). In the retrain 
setting, we applied the same processing as before, but trained a lightGBM classifier to 
predict circulatory failure on MIMIC. We formed five “replicates” of MIMIC using Monte 
Carlo resampling, in each replicate assigning admissions at random to 
training/validation/test sets in the ratio 3:1:1. Since absolute admission times were not 
available in MIMIC, temporal splits could not be constructed. Our final performance 
estimate was the mean of the performance in each replicate’s test set, and the error 
estimate was the standard deviation over replicates. In the retrain setting, the final size of 
each training set contained approximately 7,950 patients, with ~1,000 patients in the test 
sets.  
Prevalence correction for MIMIC 
The test sets used for MIMIC (validation) and MIMIC (retrain) have different prevalences of 
positive labels/events compared to the test set of the HiRID dataset. Therefore, to enable a 
comparison of the performance of circEWS-lite in terms of precision and recall between 
HiRID and MIMIC, we calibrated the precision-recall curves for MIMIC in Fig. 2b,d and 
Supplementary Fig. 7b such that MIMIC would have the same positive label/event 
prevalence as HiRID. The uncorrected precision-recall curves are shown in Supplementary 
Fig. 7a,c. The calibration was performed in different ways for the time point-based and 
alarm/event-based precision recall curves:  
• In the time slice-based evaluation the number of false alarms observed in the MIMIC 
test sets was down-scaled by multiplication with  𝑠 = ( 1prev.(HiRID) − 17 ( 1prev.(MIMIC) − 17:  
 
 
31 
where prev.(𝑑)  refers to the positive (time-slice) label prevalence in the dataset 𝑑.  
• For the calibration of the alarm/event-based precision-recall curves for MIMIC, we 
computed the AUPRC of an alarm system that was based on a random classifier and 
with the same silencing policy as circEWS-lite for both HiRID and MIMIC, which we 
denote by prev<(HiRID)  and prev<(MIMIC), respectively. The AUPRC of the 
random alarm system is the event prevalence of the dataset. We downscale the 
number of false alarms observed in the MIMIC test set with: 𝑠 = ( 1prev<(HiRID) − 17 ( 1prev<(MIMIC) − 17:  
to satisfy the assumption that the calibrated MIMIC dataset has the same event 
prevalence as HiRID.  
The correction factor 𝑠 is then multiplied with the false alarm counts when computing 
precision on the MIMIC data in order to obtain corrected precision estimates. 
Data and code availability 
The research code used to perform experiments reported in this work will be published 
under an open source license. We will also release the processed data for future studies 
under a controlled access mechanism upon publication. We are currently discussing the 
details of sharing the details with Physionet78. 
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Supplementary Figure 2 
 
Supplementary Figure 2: a: Flow chart of the exclusion criteria applied to the HiRID base cohort. b: Flow chart of the 
exclusion criteria applied to the MIMIC-III cohort. c: Flow chart of the exclusion, merging, and post-processing applied 
to the variables in the patient data management system of the HiRID cohort. 
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Supplementary Figure 3 
 
Supplementary Figure 3: Correlation of duration of circulatory failure and mortality. a: Shown is the mortality rate 
as a function of the duration of circulatory failure expressed as a fraction of length of stay in ICU. b: Shown is the 
cumulative mortality rate as a function of the frequency of occurrence of circulatory failure per hour of ICU admission.  
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Supplementary Figure 4 
 
Supplementary Figure 4: Data processing and experimental design. a: Processing details for pharmaceutical 
variables. An effective flow rate of a drug was calculated by merging continuous infusions, intravenous boluses, and 
tablets. Intravenous bolus applications and tablets do not result in a constant effective blood drug level and were 
therefore converted to an effective rate by dividing the given dose by the acting period of the drug. These acting 
periods were specified using clinical domain knowledge and are listed in Supplementary Table 5b. b: Experimental 
design. We formed five “replicate” splits with disjoint test sets (coloured, dark), and partially overlapping training 
sets (grey). The validation and test sets consisted of the most recently admitted patients, where the validation 
patients (hatched) are from an earlier period. This enabled us to select a model more likely to be generalizable to the 
future. In addition, a held-out split was formed. The test set of the split was not used for developing the models 
described in the manuscript and only assessed for preparing the publication figures to avoid subtle overfitting to the 
data set. 
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impact of training set size to address the question whether our model performance has “saturated” on the dataset 
size. This was done by artificially subsampling patients at random and retraining the model. This analysis was 
performed using the circEWS evaluation policy. We observed that model performance decreases drastically beyond 
sub-sampling to less than 5% of the original training set size, and the model did not show obvious saturation effects 
as we move to the full size of the data. c: Temporal vs. random data split. Comparison of prediction model 
performance using a random data split into train, validation and test sets, irrespective of patient admission times, 
and the temporal split strategy used in all other analyses. As the prevalences of the test sets were different, negatives 
samples of the higher-prevalence test set were sub-sampled. We observe that the unrealistic evaluation setting of 
using a random split over-estimates performance compared to retrospective model construction. d-e: Comparison 
of machine learning models. Comparison of machine learning approaches using ROC/PR curves. We considered a 
simple linear baseline (logistic regression; LogReg), a tree-ensemble based method (based on lightGBM, “GBM”; used 
to construct circEWS), an individual decision tree (based on lightGBM, “Tree”), and a recurrent neural network 
(“LSTM”). The Tree models received identical input as given to GBM. The LogReg and LSTM received normalized 
feature values. We observed that gradient-boosting ensembles clearly outperform the other methods, followed by 
LogReg and LSTM/Tree models. 
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Supplementary Figure 6 
 
Supplementary Figure 6: Silencing & resetting policy. a: Effect of silencing period. We fixed a silencing window of 
30 minutes. Here we show how overall performance (assessed by AUPRC and precision at fixed recall) varies as we 
modify this silencing time. We see that up to 7 hours of silencing results in diminished, but still high performance. 
 9 
The long silencing time is mitigated by the unsilencing mechanic, whereby a patient entering and recovering from a 
period of circulatory failure will cause silencing to be terminated early. b: Reset time. We study the impact of 
silencing the alarm after a patient exited from a state of circulatory failure, the reset time. Increasing the reset time 
results in lower AUPRC and precision due to missed deterioration events. The default value for reset time in 
circEWS is 22.5 minutes. c: Grey zone. We studied the effect of a grey zone where alarms are not counted as false 
positives. A grey zone of one hour did not lead to significantly larger precision in any direction at a p-value 
threshold of 0.05 using a student two-sample t-test. 
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Supplementary Figure 9 
 
Supplementary Figure 9: Performance of circEWS using different thresholds in different patient sub-cohorts. In 
Fig. 4, circEWS with 90% recall across the cohort is analysed in terms of its performance in different APACHE patient 
groups, APACHE severity groups and age groups. This figure analyses the performance of circEWS with other recall 
values, namely 80% and 95%, also with the same patient categorization as Fig. 4 (a,b,c). In addition, circEWS 
performance in sub-cohorts categorized by gender and admission types, i.e., elective versus emergency and non-
surgical versus surgical, is also analysed (d and e). 
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own, respectively. d: Shapelet feature types. All possible shapelet feature extraction methods were compared by 
training the GBM classifier on the 5 development splits. Selection of statistically significant shapelets had little 
influence on the results - we therefore picked the min-max procedure because it theoretically guarantees diversity 
among selected shapelets. More importantly, computing features at multiple timelags (dist-set) outperformed other 
feature generation approaches. Therefore, we chose to extract min-max dist-set shapelet features for circEWS. e: 
Effect of number of features. We studied the effect of the number of features on model performance. We first 
ranked each feature by its mean absolute SHAP value in a model trained on 50% of the data using all 5,278 features. 
The dashed line indicates results from the model trained on 50% of the data; using the full training data is 
computationally prohibitive. We marked 1,763 as the number of features whose mean absolute SHAP value is non-
zero. We saw that more features increase model performance until a saturation point occurs. These results are on 
the held-out test set, but the decision to use the top 500 features was made on the development test set, which 
showed qualitatively similar results. 
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Frequency Median sampling interval Short horizon Medium horizon Long horizon Very long horizon
High < 1 5 mins 3 0 mins 6 0 mins 24 0 mins 720 mins
Medium > 1 5 mins, < 8 hours 1 2 hours 24 hours 3 6 hours 4 8 hours
Low ≥ 8 hours 1 6 hours 3 2 hours 4 8 hours 72 hours
a
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[Dop> 0 µg/min], [Mil > 0 µg/min], [Lev> 0 µg/min], [Theo> 0 µg/min],
Event L1 := [(vLac ≥ 2 or aLac ≥ 2 mmol/l) and
(MAP ≤ 6 5 mmHg or Dop> 0 µg/min or Mil> 0 µg/min or Theo> 0 µg/min or
Lev> 0 µg/min],
[Noreph> 0 µg/min and Noreph< 0.1 µg/min], [Noreph≥ 0.1 µg/min],
[Epineph> 0 µg/min and Epineph< 0.1 µg/min], [Epineph ≥ 0.1 µg/min],
Event L2 := [(vLac ≥ 2 or aLac ≥ 2 mmol/l) and
(Noreph> 0 µg/min and Noreph< 0.1 µg/min or Epineph> 0 µg/min and
Epineph< 0.1 µg/min)],
[Vaso> 0 µg/min],
Event L3 := [(vLac ≥ 2 or aLac ≥ 2 mmol/l) and
(Noreph> 0.1 µg/min or Epineph> 0.1 µg/min or Vaso> 0 µg/min)]
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equal to 3 0 days if there was no
occurence of event.
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c Frequency Median sampling interval Search window Min shapelet length Max shapelet length
High < 15 mins 240 mins 30 mins 60 mins
Medium 15 mins , < 8 hours 36 hours 12 hours 24 hours
Low ≥ 8 hours 48 hours 16 hours 32 hours
d
Supplementary Figure 4: Feature details. A: Multiscale feature parameters. Overview of multi-scale horizon
lengths used for the different clinical variables during feature construction, conditional on the length of a typical sampling
interval of a variable,  shown in the second column. Variables were binned into the frequency categories of high, medium,
and low. For non-pharma variables the sampling interval is computed from the intervals between observations, and for
medications it corresponds to the effective acting periods compiled using clinical knowledge. B: List of instability 
features. Specification of the instability features computed from specific variables relevant to circulatory failure. Three
subtypes of features were constructed, corresponding to rows. The exact specification of individual conditions is listed in
brackets in the second column. The last column, in analogy to the multi-scale summaries, displays the horizon lengths 
over which time-fraction features were computed. Non-adaptive constant horizons were used. For each condition in the
first row, time-to-last occurence and current event state features are defined similarly.  C: Shapelet extraction details.
The shapelet extraction is performed on time series subsequences that precede onset of circulatory failure where the 
search window and the size of the shapelet depends on the variable sampling frequency (see Table). D:  Shapelet 
selection details. The large number of significant shapelets is reduced to a feasible set of 10 shapelets with the 
min-max selection approach: First, the shapelet with the highest accuracy selected. Afterwards, shapelets are iteratively
added such that the minimal distance to the set of already selected shapelets is maximized.
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were defined similarly. Norepinephrine is abbreviated as noreph. c: Shapelet extraction details. The shapelet 
extraction was performed on time series subsequences that precede onset of circulatory failure where the search 
window and the size of the shapelet depends on the variable sampling frequency (see Table on right). d: Shapelet 
selection details. The large number of significant shapelets is reduced to a feasible set of 20 shapelets with the min-
max selection approach: First, the shapelet with the highest accuracy was selected. Afterwards, shapelets were 
iteratively added such that the minimal distance to the set of already selected shapelets is maximized. 
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Supplementary Table 1 
 
Supplementary table 1: Patient characteristics. Although stays up to 84 days were observed, we excluded data 
after 28 days from model development and evaluation. 
Sex
Male 63.49% 22919 admissions
Female 36.51% 13178 admissions
Age (years)
Median (Mean) 66 (62.98)
Range 16-98
Length of stay (days)
Median (Mean) 0.93 (2.09)
Range 0-84
Admission type
Emergency 55.49% 20032 admissions
Not emergency 42.49% 15337 admissions
Unknown 2.02% 729 admissions
Surgical status
Yes 55.25% 19944 admissions
No 42.00% 15070 admissions
Unknown 3.00% 1084 admissions
APACHE diagnostic group
Cardiovascular
Surgical 23.68% 8547 admissions
Nonsurgical 12.96% 4677 admissions
Neurological
Surgical 11.32% 4088 admissions
Nonsurgical 17.36% 6266 admissions
Respiratory
Surgical 1.87% 675 admissions
Nonsurgical 7.46% 2694 admissions
Trauma
Surgical 0.71% 258 admissions
Nonsurgical 4.45% 1608 admissions
Other 20.17% 7280 admissions
Unknown 0.01% 5 admissions
Circulatory dysfunction
Patients with events 30.60% 11046 admissions
Mean events per patient with event 4.16
Mean event duration 320 minutes
Mean time to first event 492 minutes
Mortality 6.11% 2205 admissions
APACHE score
Mean (std) 17.46 (7.86)
Median (25%, 75%) 16 (12, 22)
Range [0, 57]
Supplementary Table 1: Patient statistics. Statistics of the cohort used for model development. Although 
stays up to 84 days are observed, we exclude data after 28 days from model development and evaluation.
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Supplementary Table 2 
 
Supplementary Table 2: Hyperparameters. a: Fixed hyperparameters for tree-based models. Fixed 
hyperparameters used for tree-based (ensemble) models implemented using the lightGBM library. Full and 
compact models used the same hyperparameters, as well as the decision tree baseline, except that no random sub-
sampling of the training set was used in the latter case. b: Hyperparameter grid and optimal values for tree-based 
models. Hyperparameter search space for the grid search for tree-based models implemented using the lightGBM 
library, yielding a grid size of 20. Decision trees had a reduced grid because feature/training set sub-sampling is not 
applicable for them. The last row shows the effective number of trees that are added to the ensemble, using early-
stopping on the validation set, for the full/compact model respectively. c: Fixed/grid hyperparameters and optimal 
values for LR. Hyperparameter search grid and fixed hyperparameters for the LogReg model. Only the 
regularization parameter weighting the L2 weight decay was included in the grid. The ‘Optimal’ learning rate 
schedule is based on a heuristic by Leon Bottou, and the early stopping tolerance refers to the minimal 
improvement on the training/validation loss that is achieved in every epoch until the optimization is early stopped. 
enilesaBledomdecudeRledomecnerefeRretemaraP
50.050.050.0etargninraeL
EURTEURTEURTedomdecnalabnU
reveN%001%001eertrepgnilpmas-bustesgniniartfoycneuqerF
golhtpedmumixaM 2(Max number of leaves) log2(Max number of leaves) log2(Max number of leaves)
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b
c
lamitpoledomecnerefeRegnaRretemaraP
Hidden state dimension
temporal U{1000, 2000} 1756
static U{2, 4 } 3
joint {2α : α ∈ U{4 , 7}} 16
Learning rate {10γ : γ ∈ U(−5,−2)} 1.2× 10−4
Dropout U(0.2, 0.8 ) 0.38
Activation function {relu, tanh, sigmoid} tanh
d
Supplementary Table 3: Hyperparameters. A: Fixed hyperparameters for tree-based models. Fixed 
hyperparameters used for tree-based (ensemble) models implemented using the lightGBM library. Full and compact
models use the same hyperparameters, as well as the decision tree baseline, except that no random sub-sampling
of the training set is used in the latter case. B: Hyperparameter grid and optimal values for tree-based
models. Hyperparamet r earch space for the grid e rch for tree based models implemented using the ligh GBM
library, yielding a grid size of 20. Decision trees have a reduced grid because feature/training set sub-sampling is
not applicable for them. The last row shows the eff ctive number of trees that ar  added to the ensemble, sing
early-stopping on the validation set, for the full/compact model respectively. C: Fixed/grid hyperparameters 
and optimal values for LR. Hyperparameter search grid and fixed hyperparameters for the LogReg model. Only
the regularization parameter weighting the L2 weight decay is included in the grid. The ‘Optimal’ learning rate 
schedule is based on a heuristic by Leon Bottou, and the early stopping tolerance refers to the minimal improvement
on the training loss that is achieved in every epoch until the optimization is early stopped. D: Hyperparameter 
range and optimal values for LSTM. Random search was used to search for the optimal set of hyperparameters
with the specified range for the LSTM models, and 16 sets of hyperparameters were randomly drawn. Early stopping
based on the validation results was also used during model training.
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d: Hyperparameter range and optimal values for LSTM. Random search was used to search for the optimal set of 
hyperparameters with the specified range for the LSTM models, and 16 sets of hyperparameters were randomly 
drawn. Early stopping based on the validation results was also used during the model training. 
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Supplementary Table 3 
 
Supplementary Table 3: Description of time-point artefacts and corresponding solutions in HiRID. 
  
Timestamp artifact description (of a variable for a patient) Solution
The SampleTime and the EnterTime di↵er in the “year” but not in the “month” field. Replace the value of the “year” field in the SampleTime
with that of the EnterTime.
The SampleTime and the EnterTime di↵er in both the “year” and the “month” fields, and the “year”
of the EnterTime is the same as the “year” of the SampleTime in the next record.
Delete all records with SampleTime earlier than
AdmissionTime.
The SampleTime and the EnterTime di↵er in both the “year” and the “month” fields, and the
SampleTime of the current and the next record only di↵ers in the “month” field, but the SampleTime
of the current record and the EnterTime of the previous/next record has the same “year”.
Replace the value of the “year” field in the SampleTime
with that of the previous/next record.
The SampleTime and the EnterTime di↵er in the “month” not in the “year” field, and the absolute
di↵erence in “day” is smaller than 2 days.
Replace the value of the “month” field in the
SampleTime with that of the EnterTime.
The SampleTime and the EnterTime di↵er in the “month” not in the “year” field, and the absolute
di↵erence in “day” is larger than 1 day, but the SampleTime of the current and the previous/next record
has the same “day”.
Replace the value of the “day” field in the SampleTime
with that of the previous/next record.
The absolute di↵erence in “month” between the SampleTime and the EnterTime is 11, and the
SampleTime and the EnterTime is the same in “month” in the previous/next record.
Add/subtract one from the “year” value of the
SampleTime of the record.
The “month” and “day” of SampleTime are swapped compared to EnterTime. Swap “month” and “day” of SampleTime according to
EnterTime.
Uncorrectable SampleTime resulting in a long time gap at the end of the stay, and the number of records
after the gap is less than 5 % of the total number of records.
Delete all records after the gap.
The units digit of the “month” of the SampleTime is swapped with the tens digit of the “day” of the
SampleTime.
Swap back the units digit of the “month” of the
SampleTime with the tens digit of the “day” of the
SampleTime.
The span of SampleTime of the records before the gap is larger than a day while the span of the
EnterTime of the records is smaller than 6 hours, i.e. the records are history long before the admission.
Delete all records before the AdmissionTime.
The SampleTime and the EnterTime only di↵er in the tens digit of the “day” field, i.e. the di↵erence in
“day” is a multiple of 10.
Replace the value of the “day” field in the SampleTime
to that of the EnterTime.
The date of the EnterTime is the end of a month X but the date of the DateTime is the beginning of
the month X-1 or X.
Replace the “month” of the DateTime with X+1.
The SampleTime of the last record before the gap is before the AdmissionTime (or the SampleTime of
the first monvals record for non-monval tables), and the total number of records before the gaps is less
than 10 % of the total number of records.
Delete all records before the gap.
The SampleTime of the first record after the gap is after the SampleTime of the last monvals record for
non-monval tables, and the total number of records after the gaps is less than 10 % of the total number
of records.
Delete all records after the gap.
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Supplementary Table 4 
.  
Supplementary Table 4: Forward variable selection. Shown is the rank (column 1) of a variable (column 2) and 
performance increase (column 3) in forward variable selection. Point estimates of the ranks were obtained on the 
held-out split and the standard deviations of the ranks were obtained by running the same procedure on the five 
development splits. The performance was measured using the AUPRC (time-slice based evaluation) on the 
validation set. A lightGBM model with fixed hyperparameters was used (at most 64 leaves per tree, and 
column/row sampling ratios of 75% per tree, using early stopping after 20 epochs of no change). The third column 
indicates the AUPRC improvement that was obtained by adding this variable to the best model obtained so far, only 
using variables in rows above the variable. ‘None’ indicates that no improvement resulted from the addition of the 
variable. The best model obtained by this procedure contains 18 variables (and the last variable included in the 
model is marked with *). 
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901.0+PAM)2.1(2
820.0+sciseglanadioipo-noN)0.7(3
600.0+)rotalitneV(erusserpyrotaripsnikaeP)3.4(4
900.0+negyxolatnemelppuS)2.5(5
100.0+noissimdaUCIecnisemiT)5.3(6
enoN,enimatuboD)2.3,9.1,9.1,6.3(01-7
Milrinone,
Levosimendan,
Theophylline
enoNnietorpevitcaer-C)8.4(11
enoNSSAR)6.5(21
300.0+tuptuocaidraC)0.3(31
enoNesoculgmureS)4.2(41
enoNPBcilotsaiD)1.7(51
OpS)8.3(61 2 None
enoNetartraeH)6.5(71
400.0+egatneitaP)2.3(*81
enoNRNI)0.5(91
enoNPBcilotsyS)0.6(02
Sup lementary Table 5: Forward variable sel ction. Ranking of the top 20 variables for predicting circulatory
failure by their addition order in a greedy forward selection of variables. The point estimates of the ranks were
obtained on th  held-out split and the standard deviations of the ranks were obtained by running the sam  
procedure on the 5 development splits. The performance was measured using the AUPRC (time-slice based
evaluati n) on the validation set. A lightGBM model with fixed hyperparamet rs was used, with at ost 64 leaves
per tree, and column/row sampling ratios of 75 % per tree, using early stopping after 20 epochs of no change. The
third column indicates the AUPRC improvement that was obtained by adding this variable to the best model thus 
obtained, only using variables in rows above the variable. ‘None’ indicates that no improvement resulted from the
addition of the variable. The best model obtained by this procedure contained 18 variables in is marked with a *.
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Supplementary Table 5: 
 
 
Supplementary Table 5: List of variables in circEWS model. This table lists the full set of variables used in our models. 
The “full” model uses 112 variables associated with the top 500 features. The “compact” model uses only features 
from the top-20 variables, excluding those not identifiable in MIMIC, resulting in 17 variables generating 176 features. 
Where relevant, we further provided the chosen mapping to MIMIC ITEMIDs, as well as the default values used in 
imputation (selected using prior clinical knowledge), and the range of permitted values for artefact removal. 
 
 
 
List of variables included (and # of features per variable)
in full model (top 500 features).
Supplementary excel sheet  “circEWS_Variables_Overview_Table.xlsx”
Columns in this spreadsheet
- Variable name
- #features derived from this variable
- Inclusion of variable in compact model
-  Relevant MIMIC identifiers
- Default value
- Permitted range of values
- Type (continuous, binary, categorical)
Further sheets
- List of drugs comprising combined drugs
- List of variables formed from merging other variables (non-drugs)
Supplementary Table 4: ist of vari bles in Top 500 model. This table lists t e full set of variables used in
our models and is provided as a supplementary XLS file. The “full” model uses 112 variables associated with the
top 500 features. The “compact” model uses only features from the top-20 variables, excluding those not identifiable
in MIMIC, resulting in 176 features. We further provide, where relevant, the mapping to MIMIC ITEMIDs we chose, 
as well as the default value used in imputation (selected using clinical prior knowledge), and the range of permitted
values applied using artifact removal.
